Oxford coronavirus vaccine Covishield may launch in November: Adar Poonawalla, CEO, Serum Institute
Good News | July 23, 2020 11:02 ISTOxford coronavirus vaccine, whose results of Phase I, II trials have appeared safe, will be called 'Covishield' in India, says Adar Poonawalla, CEO, Serum Institute of India, a Pune based manufacturing partner of AstraZeneca that will be producing 1 billion doses of the Oxford's corona vaccine.